The Network Submits Comments on GLOBE Model Proposed Rule

The Network recently submitted comments to the Centers for Medicare and Medicaid Services (CMS) on its Global Benchmark for Efficient Drug Pricing (GLOBE) Model proposed rule, which offers a rebate framework to lower the cost of Part B drugs.

In its letter, The Network reiterated its opposition with mandatory federal drug pricing models due to the potential adverse impact on provider viability and patient access. However, The Network noted that the GLOBE model is structured “in a way that recognizes the need to avoid unnecessary financial risk to physicians, an important distinction from previous drug pricing policies.”

The Network goes on to urge policymakers to implement similar considerations for Part B drugs with prices negotiated under the Inflation Reduction Act (IRA). “In addition to CMS’s ongoing efforts related to GLOBE, the Network urges CMS to work with Congress to advance the Protecting Patient Access to Cancer and Complex Therapies Act, championed by Senator John Barrasso (S. 2764, 118th Congress) and Representative Greg Murphy, M.D. (H.R. 4299 119th Congress),” the letter reads.

To read the comment letter, CLICK HERE.